Hormone Therapy for Breast Cancer Survivors with Dr. Mindy Goldman

20 Aug 2025 · 61 min
Episode

20 Aug 2025 · 61 min

0:00

In this episode of the Well Beyond 40 podcast, host JJ Virgin interviews Dr. Mindy Goldman, Chief Clinical Officer of MITTY Health and a clinical professor emeritus at UCSF, about hormone replacement therapy (HRT) for breast cancer survivors. Dr. Goldman explains that breast cancer is a heterogeneous group of diseases and that hormone‑receptor status (about one‑third hormone‑negative, two‑thirds hormone‑positive) determines whether HRT can be considered. She critiques the Women’s Health Initiative, noting that increased breast‑cancer risk was linked to synthetic progestins, while bioidentical progesterone appears safer. The conversation highlights the lack of large randomized trials for bioidentical hormones, the nuanced role of estrogen‑only therapy, and the need for individualized shared‑decision making. The episode surveys a toolbox of symptom‑management options for menopausal women who are cancer survivors: non‑hormonal pharmacologic agents (low‑dose antidepressants, gabapentinoids, anti‑seizure meds, overactive‑bladder drugs) and the new NK3‑receptor antagonist fezolinant/Vioza for hot flashes; vaginal estrogen formulations (creams, rings, suppositories) and their safety data; and limited evidence for testosterone use. Dr. Goldman discusses side‑effects of tamoxifen and aromatase inhibitors, their impact on bone density, joint pain, and vaginal dryness, and proactive strategies using supplements, sleep hygiene, timed eating, and targeted therapies. Lifestyle prevention strategies are highlighted: regular high‑intensity interval exercise (≥150 min/week), limiting alcohol (≤2‑3 drinks/week), Mediterranean‑style diet, maintaining healthy body composition (reducing visceral adipose tissue), and potential benefits of heat‑based therapies (sauna, cold plunge). The process for evaluating a new breast lump—clinical exam, diagnostic mammogram, ultrasound, fine‑needle aspiration or core biopsy, and subsequent management—is outlined. Dr. Goldman describes MITTY Health, a virtual, insurance‑covered telehealth network that integrates menopause care with breast‑cancer survivorship, offering evidence‑based protocols, provider training, and a national cancer platform. Throughout, the dialogue emphasizes shared decision‑making, up‑to‑date guidelines (NCCN, ACOG), and the goal of preventing unnecessary suffering for survivors. Sponsor reads and calls to action are present but peripheral to the core content.

Chapters

More from JJ

33:47
Podcast

Regenerating Your Joints Safely with Dr. Ashu Goyle

2mo ago
40:29
Podcast

All About Supplements

2mo ago
11:54
Podcast

Revolutionize Your Longevity with AI

2mo ago
59:31
Podcast

Dan Pardi Reveals Vitamin C's Surprising Anti-Aging Power

2mo ago
10:16
Podcast

BBLs, Facelifts, and Fillers with Dr. Rady Rahban with Dr. Rady Rahban

3mo ago
1:00:39
Podcast

How to Protect Your Menopausal Gut with Dr. Kiran Sachdev

3mo ago
41:12
Podcast

Healthy Revisit: Heavily Meditated - Transforming Your Emotional Landscape with Dave Asprey

3mo ago
14:20
Podcast

Busting Plastic Surgery Myths After 40

3mo ago
1:05:53
Podcast

Why Zane Griggs Believes Extreme Biohacking Fails You

3mo ago
56:33
Podcast

Healthy Revisit: Ancient Wisdom Meets Modern Neurology with Dr. Trupti Gokani

3mo ago
14:24
Podcast

Herbal Medicine For Menopause

3mo ago
See all content